PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result - June 23, 2019 - Arteric
Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. “Adding... - June 22, 2019 - Cayman Chemical Company
CovalX has partnered with Shimadzu Scientific Instruments to offer the OMEGATOF, an integrated MALDI solution for ultra high-mass detection. With a focus on the detection of large molecules, including biotherapeutics, protein complexes, aggregates, and antibody-antigen interactions in a benchtop footprint... - June 13, 2019 - CovalX
Study Tracks Utilization of Real-World Data (RWD), Real-World Evidence (RWE) and Supportive Services and Implications to CROs. - June 11, 2019 - Life Science Strategy Group, LLC
The Global Regenerative Academy is an integral part of the Global Regenerative Group, a privately-held medical technologies company specializing exclusively on Regenerative Medicine and stem cell technologies, products, and therapies that significantly enhance the body’s natural healing ability. - June 06, 2019 - Global Regenerative Group
Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and sterols to be used as research standards. - June 05, 2019 - Cayman Chemical Company
BioPhorum Operations Group extractables testing was recently completed on several of AdvantaPure’s tubing and hose products. The fluid transfer products are typically used in biopharm and pharmaceutical manufacturing processes. The Group’s standardized extractables test protocol was followed and performed by an independent lab and involved testing to four different exposure times as long as 70 days. The comprehensive testing was undertaken by AdvantaPure to meet customer requests. - May 31, 2019 - AdvantaPure
President and Chief Strategist Shares Two Case Studies That Illustrate How to Leverage Artificial Intelligence to Achieve Business Goals. - May 10, 2019 - Arteric
Sustainable entrepreneurship platform in Latin America in partnership with Endeavor, encourages innovation in health area. - May 09, 2019 - Eurofarma
Paras Biopharmaceuticals Finland Oy is proud to announce that Reuters.com / Reuters Plus has selected the Finland-based company, working on biologics manufacturing & innovations in the healthcare segment as a valued contributor to the future of healthcare solutions.
The documentary is part of their... - May 07, 2019 - Paras Biopharmaceuticals Finland Oy
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive distribution agreement with Basel, Switzerland-based Bucher Biotec AG. The agreement covers sales in Switzerland of NanoCellect’s WOLF®Cell... - May 01, 2019 - NanoCellect
Initial memory improvements following ACIST stem cells may hold promise for ALZ. - April 24, 2019 - MD Stem Cells
Standigm, an AI-powered drug discovery company, has raised $11.5 million in a Series B funding round. The funds will be used to scale the AI technology platforms and advance its drug discovery pipelines for untreatable diseases. - March 29, 2019 - Standigm
A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University Chicago and the University of Missouri – Kansas City suggests that a topical antioxidant formulation can improve the pathological signs associated with dry-eye disease. - March 26, 2019 - Experimentica Ltd
Veteran Digital Communicator Brings Decades of Award-Winning Experience to Boundary-Pushing Agency. - March 15, 2019 - Arteric
Arteric Shares Case Studies with Life Science Leaders, Illustrating Methods to Increase the Relevance and Authority of Brand Content. - March 14, 2019 - Arteric
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - March 04, 2019 - Arteric
Standigm, a company using the advanced AI technology to drug discovery, launched the customized early drug discovery and target study service, "Standigm Insight®," at 2019 BIO-Asia International Conference in Tokyo, Japan. Standigm Insight® provides AI-driven new indication prediction and novel target analysis service for customer’s in-house products. - March 04, 2019 - Standigm
Sanyal Bio has expanded into pre-clinical and clinical contract research on cannabinoids. Sanyal Bio currently holds a DEA Schedule 1 Import License for Cannabis Extracts and THC, with applications pending for Research, Analytical and Manufacturing licenses. IQVIA's DEA Compliance group is well-respected for their expertise and Sanyal Bio looks forward to working with this reputable group going forward. - February 13, 2019 - Sanyal Biotechnology
Rauwolfia Vomitoria, a Natural Plant Extract, Inhibits Cancer Stem Cells - February 08, 2019 - The Beljanski Foundation
Research Shows Pao Pereira, a Natural Plant Extract, Inhibits Cancer Stem Cells. - February 08, 2019 - The Beljanski Foundation
Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the successful development of biologically active Romiplostim (N-Plate® biosimilar) production technology.
Romiplostim has been produced with a proprietary and innovative continuous manufacturing process... - January 31, 2019 - Paras Biopharmaceuticals Finland Oy
Digital Marketing Thought Leader to Help Craft Agenda for Leading Healthcare Marketing Conference. - January 25, 2019 - Arteric
Global OrthoBiologic has announced today that it will expand its operation under the name Global REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida (globalregenerative.group) and will consist of 4 divisions, which will operate independently – Trade, Academy, Care and Finance. - January 16, 2019 - Global Regenerative Group
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. - January 12, 2019 - Bioquark Inc.
Software-Development Veteran Leads Team Renowned for Impeccable Standards. - December 21, 2018 - Arteric
Aciont Inc. announced today that data from the clinical study of the DSP-Visulex technology is published online ahead of print in Current Eye Research. Reference: Papangkorn K, Truett KR, Vitale AT, Jhaveri C, Scales DK, Foster CS, Montieth A, Higuchi JW, Brar B, Higuchi WI. Novel dexamethasone sodium phosphate treatment (DSP-Visulex) for noninfectious anterior uveitis: a randomized phase I/II clinical trial. Current Eye Research. - December 06, 2018 - Aciont Inc.
Fills talent pool at rapidly growing healthcare digital marketing agency - November 30, 2018 - Arteric
CrystalGenomics, Inc. announced today that they have signed an Export Agreement with PharmArtis International for the commercialization of Acelex® (polmacoxib) in Russia.
Based on the terms of the agreement, CrystalGenomics will supply finished product of Acelex to PharmArtis and PharmArtis will... - November 24, 2018 - CrystalGenomics, Inc.
Data Maven Brings a History of Double-Digit Growth in Client Revenue to a Growing Strategy, Analytics and Media Team. - November 16, 2018 - Arteric
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result - November 07, 2018 - Arteric
Standigm, a company using the advanced AI technology to drug discovery, launched the customized lead optimization service, "Standigm BEST®," at BIO-Europe 2018 in Copenhagen, Denmark. Standigm BEST® provides AI-driven lead optimization and can also be utilized for fast-follow hit identification or patent fencing strategy. One-to-one meetings have been scheduled with leading pharmaceutical companies, indicating their interest in Standigm BEST®. - November 05, 2018 - Standigm
Virun® and Algarithm™ offer chill vibe at otherwise chaotic Supplyside West, serve up adult beverages enhanced with DHA and flavored like deserts, to debut new vegan O3Smoothies flavor, NOT Peanut Butter and Jelly. - November 02, 2018 - VIRUN
New AdvantaSil Ultra Low Temperature Silicone Tubing is designed to aid pharmaceutical and biopharm manufacturers with protecting their high-value cell and drug products. The platinum-cured tubing is engineered for Single-Use applications involving cold storage and transport. It’s the first commercially-available tubing engineered for flexibility and crush resistance upon removal from a minus 86 degrees C freezer. A video on AdvantaPure’s website shows the test procedures and results. - November 01, 2018 - AdvantaPure
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - October 26, 2018 - Arteric
Broad Digital Experience and Deep Client Commitment Augment Stellar Account Team. - October 26, 2018 - Arteric
Total Number of Awards Reaches 13. - October 12, 2018 - Arteric
Digital Marketing Agency Continues Support of Major Healthcare Conference - October 05, 2018 - Arteric
Veteran Digital Marketing Strategist Guides Discussion on Personalization Strategies - September 21, 2018 - Arteric
The results of the clinical trial Cyclatop (NCT02865356) to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019 (Cyclosporine A 5% topical spray) across all group ages, for the treatment of mild to moderate atopic dermatitis, were presented today at the EADV Congress in Paris. SP14019 showed excellent safety and acceptability profile, clinically relevant and statistically significant efficacy with respect to placebo and very low systemic exposure to Cyclosporine A. - September 15, 2018 - Spherium Biomed
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
CrystalGenomics, Inc. announced today that they have signed an Export Agreement with Apsen Farmacêutica for the commercialization of Acelex® (polmacoxib) in Brazil.
Under the terms of the agreement, Apsen will secure exclusive rights for the Brazilian market to sell and market Acelex 2mg,... - September 05, 2018 - CrystalGenomics, Inc.
Expands Content Development and Management Options for Healthcare Marketers - August 31, 2018 - Arteric
Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners
Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a curated lipid standards database. - July 21, 2018 - Cayman Chemical Company
Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive assay... - July 20, 2018 - Cayman Chemical Company
Healthcare Digital Marketing Agency Recognized for Award-Winning, Ground-Breaking Work. - July 17, 2018 - Arteric
Three new case studies from AdvantaPure highlight fluid transfer challenges in the biopharm and pharmaceutical industries. One study explores leak-proof container systems coupled with the goal of foam reduction. Another focuses on Single-Use molded tubing assemblies in a final fill application. The third examines how a customer decided between movable totes and two styles of clean room wall pass-through systems. - July 14, 2018 - AdvantaPure
Evan Unger, MD, President and CEO of NuvOx Pharma, announced that NuvOx has received a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to fund the development of a new strategy to detect pancreatic cancer. The grant, 2R44CA203090-02, entitled “Thy-1... - July 14, 2018 - NuvOx Pharma
4 Communicator Awards Raise Total to 8 Trophies From 3 Competitions - July 10, 2018 - Arteric